Uveal melanoma is a malignancy with exceptional features for treatment with
immunotherapy. Primary uveal melanoma can be treated with a variety of therapies that may …

Uveal melanoma (UM) is a rare cancer with a high mortality rate. In comparison to
cutaneous melanoma, UM has unique immunological features. Arising in the immune …

Uveal melanoma is the most common primary intraocular tumor in adults. 1 Before the mid-
20th century, enucleation was the mainstay of treatment for uveal melanoma. Although this …

Uveal melanoma (UM) is the most common primary intraocular cancer in adults. The
incidence in Europe and the United States is 6-7 per million population per year. Although …

There is currently a renewed interest in the development of immunotherapies for cancer
patients. Many of these experimental treatments are now in different stages of clinical trials …

Uveal melanoma is the most prevalent primary intraocular tumour in adults with the
incidence between five and six cases per million people in the United States and Europe …

Introduction Uveal melanoma (UM) is the most common intraocular cancer and represents a
discrete subtype of melanoma. Metastatic disease, which occurs in half of patients, has a …

Uveal melanoma is an intraocular malignancy that, depending on its size and genetic make-
up, may lead to metastases in up to 50% of cases. Currently, no therapy has been proven to …

Uveal melanoma, a rare subset of melanoma, is the most common primary intraocular
malignancy in adults. Despite effective primary therapy, nearly 50% of patients will develop …

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults.
Conventional methods of UM treatment are based on chemotherapy and radiotherapy …